Best Sylvant (Siltuximab) Medicine in India

Sylvant (Siltuximab) is a targeted biological treatment used for adults with multicentric Castleman disease (MCD) who are human immunodeficiency virus (HIV)-negative and human herpesvirus-8 (HHV-8)-negative. Siltuximab works by targeting interleukin-6 (IL-6), a protein involved in inflammation and the abnormal growth of immune cells, helping to reduce disease activity and related symptoms.

Sylvant (Siltuximab) is a monoclonal antibody that binds to IL-6 and prevents it from interacting with its receptor. By blocking excessive IL-6 signaling, it helps reduce the inflammatory processes and abnormal immune-cell activity associated with multicentric Castleman disease.

Sylvant (Siltuximab) is administered as an intravenous infusion by a healthcare professional. Treatment is given according to your doctor's prescribed schedule, and you should attend all appointments for monitoring and follow-up. Before treatment, inform your doctor about any infections, medical conditions, or medicines, vitamins, herbal products, or supplements you are taking.

Treatment of Multicentric Castleman Disease

Sylvant (Siltuximab) is used to treat adults with multicentric Castleman disease (MCD) who are HIV-negative and HHV-8-negative. By blocking interleukin-6 (IL-6), it helps reduce excessive inflammation and abnormal immune-cell activity associated with the disease, which may help control symptoms and reduce disease activity.

Some side effects of Sylvant (Siltuximab) may improve as the body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Sylvant (Siltuximab)

Sylvant (Siltuximab) is given as an intravenous infusion by a qualified healthcare professional. It is usually administered once every 3 weeks according to your doctor's prescribed schedule. The treatment should be continued as recommended, with regular medical check-ups to monitor your response and overall health. Your doctor may delay treatment if you have an active infection or certain abnormal blood test results.

Sylvant (Siltuximab) is a monoclonal antibody that specifically targets interleukin-6 (IL-6), a protein that plays an important role in inflammation and abnormal immune activity. It binds to IL-6 and prevents it from activating its receptor, thereby reducing excessive inflammatory signaling and helping control the abnormal immune response associated with multicentric Castleman disease.

• Keep the unopened vial refrigerated between 2°C and 8°C.
• Do not freeze the vial, and protect the product from direct light.
• Store the vial in its original carton until it is ready for preparation.
• After reconstitution and dilution, use the prepared solution within the specified stability period; up to 8 hours at room temperature has been demonstrated.

Alcohol CONSULT YOUR DOCTOR

Avoid or limit alcohol unless your doctor confirms it is safe, as alcohol may worsen certain side effects or affect your overall health during treatment.

Pregnancy CONSULT YOUR DOCTOR

Inform your doctor if you are pregnant or planning to become pregnant. Your doctor will assess the potential benefits and risks before and during treatment.

Breastfeeding CONSULT YOUR DOCTOR

Discuss breastfeeding with your doctor before starting treatment. Your doctor can advise whether breastfeeding should be avoided during treatment.

Driving CONSULT YOUR DOCTOR

Sylvant (Siltuximab) may cause dizziness, fatigue, or other symptoms in some people. Avoid driving or operating machinery if you feel dizzy, tired, or unable to remain alert.

Kidney CAUTION

Tell your doctor if you have kidney problems or any history of kidney disease. Your doctor may monitor your health and laboratory results during treatment.

Liver CAUTION

Inform your doctor about any liver problems before treatment. Your doctor may recommend regular blood tests to monitor liver function during treatment.

• Attend all scheduled appointments because Sylvant (Siltuximab) is given by a healthcare professional through intravenous infusion.
• Inform your doctor about all medicines, vitamins, herbal products, and supplements you are taking.
• Report fever, chills, cough, sore throat, or other signs of infection promptly, as treatment may affect your immune response.
• Follow your doctor's advice about blood tests and regular monitoring throughout treatment.
• Tell your doctor immediately if you experience difficulty breathing, severe allergic symptoms, unusual swelling, or other sudden changes during or after the infusion.
• Read More About - Sylvant (Siltuximab) from Pharma Five.

Pharma Five, can facilitate patients in importing Sylvant (Siltuximab) in small quantities for personal use. To proceed, the applicant is required to submit an application in Form 12A along with a prescription provided by a Registered Medical Practitioner (RMP).

Pharma Five supports patients requiring Sylvant (Siltuximab) by providing professional pharmaceutical consultancy and assistance with accessing specialized products through appropriate import facilitation. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.